Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Google News
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Biogen, Sage Scrap Essential Tremor Study After Phase II Failure - BioSpace
Phase II study of SAGE-324 misses goals - The Pharma Letter
Phase II study of SAGE-324 misses goals - The Pharma Letter
Merck lays off workers amid rough pharma job market - STAT
Merck lays off workers amid rough pharma job market - STAT
Sage Therapeutics’ stock dives as failed trial hits Biogen collaboration - MarketWatch
Sage Therapeutics’ stock dives as failed trial hits Biogen collaboration - MarketWatch
Sage Therapeutics' stock dives as failed trial hits Biogen collaboration - Morningstar
Sage Therapeutics’ stock dives as failed trial hits Biogen collaboration - MarketWatch
Sage Therapeutics Shares Tumble Premarket on Essential Tremor Study Failure - MarketWatch
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
×